Evidence map›Paper›PMID 33467716›Full record

ArticlePlants (Basel, Switzerland)2021

Differentiation of

Mavis Hong-Yu Yik, Bobby Lim-Ho Kong, Tin-Yan Siu, David Tai-Wai Lau, Hui Cao, Pang-Chui Shaw

Open access · goldAbstract read
In one paragraph

Article in Plants (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 41 citations in OpenAlex.

  1. Complete chloroplast genome and phylogenetic analysis ofMitochondrial DNA. Part B, Resources · 2026
    Article
  2. The complete chloroplast genome sequence of the medicinal plantMitochondrial DNA. Part B, Resources · 2026
    Article
  3. The complete chloroplast genome and phylogenetic analysis ofMitochondrial DNA. Part B, Resources · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Comparative Analysis of Chloroplast Genomes ofPlants (Basel, Switzerland) · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Evidence-based complementary and alternative medicine : eCAM · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Mavis Hong-Yu YikLi Dak Sum Yip Yio Chin R & D Center for Chinese Medicine, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong, China.ORCID 0000-0001-5029-819X
Bobby Lim-Ho KongLi Dak Sum Yip Yio Chin R & D Center for Chinese Medicine, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong, China.
Tin-Yan SiuShiu-Ying Hu Herbarium, School of Life Sciences, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong, China.
David Tai-Wai LauLi Dak Sum Yip Yio Chin R & D Center for Chinese Medicine, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong, China.
Hui CaoResearch Center for Traditional Chinese Medicine of Lingnan (Southern China) and College of Pharmacy, Jinan University, Guangzhou 510632, China.
Pang-Chui ShawLi Dak Sum Yip Yio Chin R & D Center for Chinese Medicine, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong, China.
Chinese University of Hong Kong · HKJinan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chinese herbal tea, also known as Liang Cha or cooling beverage, is popular in South China. It is regarded as a quick-fix remedy to relieve minor health problems.

Indexed as

authenticationchloroplast genomeDNA barcodeHedyotisherbal medicinendhDrps16-trnQycf1

Identifiers

PMID33467716
PMCPMC7829813
OpenAlexW3119235600

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.